EUVIMEDEUVIMED entdecken
Leserbrief

Response to the Letter Regarding “Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis”

Masahiko Tameda iD, Hayato Nakagawa iD

Hepatology Research · 2026-11 · 56 (11) · 1765-1766

DOI: 10.1111/hepr.70236 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Hepatology Research, online erschienen am 03.07.2026. Verfasst von Masahiko Tameda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Mie, Japan. Die Arbeit nennt 8 Literaturangaben. Gefördert von: JSPS KAKENHI, AMED.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

ORCID-Profile: Masahiko Tameda, Hayato Nakagawa

Förderung

  • JSPS KAKENHI
  • AMED

Zitieren

APA

Tameda, M., & Nakagawa, H. (2026). Response to the Letter Regarding “Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis”. Hepatology Research, 56(11), 1765-1766. https://doi.org/10.1111/hepr.70236

Vancouver

Tameda M, Nakagawa H. Response to the Letter Regarding “Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis”. Hepatology Research. 2026;56(11):1765-1766. doi:10.1111/hepr.70236

BibTeX
@article{Tameda2026,
  author = {Tameda, Masahiko and Nakagawa, Hayato},
  title = {Response to the Letter Regarding “Efficacy and Safety of Hypofractionated Radiation Therapy Combined With Immunotherapy for Hepatocellular Carcinoma With Vp4 Portal Vein Tumor Thrombosis”},
  journal = {Hepatology Research},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {1765--1766},
  doi = {10.1111/hepr.70236}
}
Kostenlos starten →